✦ LIBER ✦

A phase II study of chronomodulated (CHR) 5-fluorouracil (5-FU) and leucovorin (LV) in combination with epirubicin (EPIDX)and Cis-Platin (CDDP) in the treatment of metastatic gastric carcinoma (MGC)

✍ Scribed by Bertuccelli, M.; Falcone, A.; Brunetti, I.; Pfanner, E.; Allegrini, G.; Panduri, T.; Lencioni, M.; Conte, P.F.

Book ID: 122398680
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 265 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(97)86169-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

272 A multicenter prospective phase II s

272 A multicenter prospective phase II study of oxaliplatin (OXA), 5-fluorouracil 95FU) and leucovorin (LV) followed, by irininotecan (IRI), 5FU and LV after progression, in patients (pts) with untreated metastatic colorectal carcinoma (MCRC)

✍ C. Almanza; L. De Paz; M. Valladares; M. Jorge; S. Candamio; M. Salgado; C. Cast 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

A Phase II Study of ANGIOZYME® in combin

A Phase II Study of ANGIOZYME® in combination with 5-fluorouracil, leucovorin and ironotecan in the treatment of metastatic colorectal cancer patients

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Randomized Multicenter Phase II Trial of

Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Federation Francophone de Cancerologie Digestive Group Study--FFCD 9803

✍ Bouche, O. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 357 KB

Salvage chemotherapy with high-dose leuc

Salvage chemotherapy with high-dose leucovorin (lv) and 5-fluorouracil (5-fu) 48-hour continuous infusion (ci) in combination with conventional doses of cyclophosphamide (c) in anthracycline/taxane refractory metastatic breast cancer (mbc) patients. A phase II study

✍ Kalbakis, K.; Agelaki, S.; Androulakis, N.; Kakolyris, S.; Kouroussis, C.; Mavro 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase II study of alternating cycles o

A phase II study of alternating cycles of CPT-11 and high-dose 48 hour infusion 5-FU in combination with leucovorin (HD-5-FU/LV) in no selective patients with metastatic colorectal cancer (MCRC)

✍ G. Rosati; D. Bilancia; S. De Santis; A. Dinota; A. Rossi; L. Manzione 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A phase II study of 5-fluorouracil, leuc

A phase II study of 5-fluorouracil, leucovorin, and interferon-α in the treatment of patients with metastatic or recurrent gastric carcinoma : An Eastern Cooperative Oncology Group study (E5292)

✍ Gary R. Hudes; Stuart Lipsitz; Jean Grem; Mary Morrisey; Louis Weiner; John W. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Chemotherapy has a limited impact on adenocarcinoma of the stomach. Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-␣ (IFN-␣) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been ext